insights_auto
Why is EDIT down 3,39%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
US$1,71
arrow_downward
-3,39%(-0,060) 1D
US$1,70
arrow_downward
-0,58% (-0,0100)todayPre-market
Closed: 19 ພ.ຈ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
US$1,80
High
US$1,83
Low
US$1,70
Mkt. cap
263,92 ລ້ານ
Avg. vol.
2,38 ລ້ານ
Volume
1,14 ພັນ
52-wk high
US$3,94
52-wk low
US$1,66
EPS
US$-0,62
Beta
2,09
Shares outstanding
154,34 ລ້ານ
No. of employees
87
Open
US$1,80
High
US$1,83
Low
US$1,70
Mkt. cap
263,92 ລ້ານ
Avg. vol.
2,38 ລ້ານ
Volume
1,14 ພັນ
52-wk high
US$3,94
52-wk low
US$1,66
EPS
US$-0,62
Beta
2,09
Shares outstanding
154,34 ລ້ານ
No. of employees
87
News stories
From web sources and news partners
Adam Feldman | Substack
·
18 ຊົ່ວໂມງກ່ອນ
Inside the Federal Litigation of Five S&P 500 Giants
RealMoney Pro
·
13 ຊົ່ວໂມງກ່ອນ
Anthropic Pops, but the S&P 500 Drops
Trefis
·
5 ຊົ່ວໂມງກ່ອນ
S&P 500 Movers | Winners: PANW, OKTA, P | Losers: WSM, TWLO, AMD
The Harvard Law School Forum on Corporate Governance
·
23 ຊົ່ວໂມງກ່ອນ
Board Practices and Composition in the Russell 3000 and S&P 500
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
Foundedພ.ຈ. 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com